CyberSAR Articles

CyberAIDD assisted analysis of drug discovery article Titled “Discovery and functional characterization of a potent, selective and metabolically stable PROTAC and Protein kinases DYRK1A and DYRK1B

CyberAIDD assisted analysis of drug discovery article Titled “Discovery of Potent Orally Bioavailable Tricyclic NLRP3 Inhibitor”

CyberAIDD assisted analysis of Drug Discovery article titled Discovery of JNJ-748566665, A Novel isoquinolone DHODH inhibitor for treatment of AML developed by Johnson & Johnson

CyberAnalysis of the molecular design and optimization of the SIK2/3 inhibitor GLPG3970 developed by Galapagos

Cyber AIDD Screening weekly Report- Androgen Receptor Degraders for Prostrate Cancer.

Cyber Weekly Report_ G-5758 a highly potent and selective oral IRE1α kinase inhibitor developed by Genentech.

Cyber-AIDD Analysis of PARK7/DJ-1 Inhibitors, probes and PROTACs Discovery and optimization

CyberAIDD Analysis CBPD-268^J an orally available CBPp300 PROTAC degrader

CyberAIDD Platform an alyzes G-protein-coupled estrogen receptor-mediated 2, 4, 5- trimethylpyridine-3-ols